Cboe UK EUR

RHKD.XC,0P0000C093,0 (RHKD.XC)

Compare
16.62
0.00
(0.00%)
At close: July 23 at 9:00:00 PM GMT+1
Loading Chart for RHKD.XC
DELL
  • Previous Close 16.62
  • Open --
  • Bid --
  • Ask --
  • Day's Range --
  • 52 Week Range 16.62 - 16.62
  • Volume --
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) -0.11
  • PE Ratio (TTM) 831.00
  • EPS (TTM) 0.02
  • Earnings Date Mar 27, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 8, 2023
  • 1y Target Est --

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. It also operates acute hospitals, medical care centers, and rehabilitation hospitals. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

www.rhoen-klinikum-ag.com

18,507

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RHKD.XC

View More

Performance Overview: RHKD.XC

Trailing total returns as of 1/24/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

RHKD.XC
0.00%
DAX P
7.46%

1-Year Return

RHKD.XC
0.00%
DAX P
28.68%

3-Year Return

RHKD.XC
1.83%
DAX P
37.11%

5-Year Return

RHKD.XC
6.04%
DAX P
59.80%

Compare To: RHKD.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RHKD.XC

View More

Valuation Measures

Annual
As of 1/24/2025
  • Market Cap

    990.69M

  • Enterprise Value

    787.75M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.44%

  • Return on Assets (ttm)

    1.71%

  • Return on Equity (ttm)

    3.62%

  • Revenue (ttm)

    1.84B

  • Net Income Avi to Common (ttm)

    44.87M

  • Diluted EPS (ttm)

    0.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    299.08M

  • Total Debt/Equity (mrq)

    10.95%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: RHKD.XC

View More

Company Insights: RHKD.XC

Research Reports: RHKD.XC

View More
Waiting for permission
Allow microphone access to enable voice search

Try again.